Estrogen receptor-positive (ER+) breast cancer is the most common breast cancer subtype.
Treatment of ER+ breast cancer comprises interventions that suppress estrogen production …

Drug discovery in the scope of cancer therapy has been focused on conventional agents
that nonselectively induce DNA damage or selectively inhibit the activity of key oncogenic …